Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
University College London Hospital is seeking a dedicated professional for a role in malignant haematology focusing on CAR-T therapy. This position offers structured training and opportunities for research development, with responsibilities including patient management and collaboration with clinical teams. The role is part of a respected NHS trust committed to high-quality care and diversity.
The use of AI is monitored, and applicants must declare its use in their supporting statement.
These roles are within the department of malignant haematology at UCLH, focusing on cellular therapy (including CAR-T) in line with JACIE standards and NHSE guidance. The T-cell Immunotherapy service at UCLH is expanding, and the post-holder will be involved in delivering:
Training will be provided in trial design, delivery, apheresis, and stem cell lab functions. The initial appointment is for 1 year from August 2025, with potential for renewal. The role offers structured training in cellular therapy and opportunities to develop research projects for MD/PhD pursuits. An honorary contract with the UCL Cancer Institute will be provided.
Responsibilities include:
UCLH is a complex NHS trust serving diverse populations with a focus on high-quality care, education, and research. It operates across multiple sites, including University College Hospital and specialized centers, and is committed to sustainability and becoming a net-zero health service by 2031 (direct) and 2040 (indirect).
Further details and responsibilities are outlined in the full Job Description. The role may involve other duties as needed, including out-of-hours on-call work. Applicants must hold at least MRCP Part I or equivalent, GMC registration, and have medical defence coverage.
UCLH is recognized as a top NHS employer, valuing diversity and flexible working. Benefits include travel loans, staff discounts, wellbeing programs, and recognition awards.